TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Patient, family may sue BPJS Kesehatan for not covering cancer drug costs

News Desk (The Jakarta Post)
Jakarta
Wed, July 18, 2018

Share This Article

Change Size

Patient, family may sue BPJS Kesehatan for not covering cancer drug costs East Jakarta resident Edy Haryadi said he may file a lawsuit if the Health Care and Social Security Agency fails to treat his wife. (Shutterstock/File)

E

ast Jakarta resident Edy Haryadi has said he is willing to go to court after he found out that the Health Care and Social Security Agency (BPJS Kesehatan) removed a cancer drug, trastuzumab, from its list of drugs that it covers.

Edy’s wife, Yuniarti Tanjung, was diagnosed with stage three HER2 breast cancer on May 10, after doctors found her lymph gland was swollen in December 2017.

A doctor at Persahabatan Hospital in East Jakarta prescribed her trastuzumab along with three other chemotherapy drugs on June 24.

However, Yuniarti did not receive the trastuzumab because the hospital said a policy issued on April 1 prevented BPJS Kesehatan from covering expenses for the drug.

The family would have to pay Rp 25 million (US$1,700) to obtain the medication.

“My wife will soon run out of time. Without trastuzumab, she probably only has one and a half more years to live,” Edy said as quoted by kompas.com on Wednesday.

“The trastuzumab could help extend her life by at least 10 years. There’s another HER2 breast cancer patient named Aryanti Baramuli who could live for another 15 years thanks to the trastuzumab."

Edy said his family was willing to file a lawsuit if the agency does not change its policy on trastuzumab.

“I hope my wife can live long enough to see our only child go to college, graduate and get married. That’s all,” he said. (vla)

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.